In this presentation, we will discuss the pathophysiology linking obesity and inflammatory bowel disease, including the impact of obesity on inflammation and the natural history of Crohn s disease and ulcerative colitis. We will also explore how dietary treatments and incretin therapies are being evaluated as adjunct therapies for the management of Crohn s disease and ulcerative colitis.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 9211 Corporate Boulevard, Suite 250
Specialties served/covered
- Adolescent Medicine
- Cardiovascular Disease
- Clinical Informatics
- Communication & Shared Decision-Making
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Health Equity & Inclusion
- Interventional Cardiology
- Medical Oncology
- Metabolic & Bariatric Surgery
- Neurology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pediatrics
- Primary care
- Psychiatry
- No reviews yet. Be the first to share yours.


